0.5352

68.35% 0.2173

After Hours: .51 -0.0252 -4.71%

Estrella Immunopharma Inc (ESLA)

Overview News Price History Financials Discussions Forecast

Estrella Immunopharma Inc stock is traded at $0.5352, with a volume of 60.63M. It is up +68.35% in the last 24 hours and down -12.41% over the past month. Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Previous Close:

$0.3179

Open:

$0.31

24h Volume:

60.63M

Relative Volume:

28.18

Market Cap:

$23.28M

Revenue:

Net Income/Loss:

$-13.25M

P/E Ratio:

-1.5149

EPS:

-0.3533

Net Cash Flow:

$-8.02M

1W Performance:

+28.19%

1M Performance:

-12.41%

6M Performance:

-69.06%

1Y Performance:

-68.33%

1-Day Range:

$0.302

$0.85

1-Week Range:

$0.295

$0.85

52-Week Range:

$0.295

$3.15

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Name

Estrella Immunopharma Inc

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

(510) 318-9098

Address

5858 HORTON STREET, SUITE 370, EMERYVILLE

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

ESLA's Discussions on Twitter

Compare ESLA vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ESLA Estrella Immunopharma Inc	0.5352	23.28M	0	-13.25M	-8.02M	-0.3533
VRTX Vertex Pharmaceuticals Inc	508.75	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.34	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.27	53.22B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.08	42.32B	5.76B	514.49M	1.10B	4.4813

Estrella Immunopharma Inc Stock (ESLA) Latest News

Sep 20, 2026

Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightChaikin Flow - dars.gov.et

Sep 20, 2026

Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightAI Trade Signals - dars.gov.et

Sep 20, 2026

Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightHigh Dividend Factor - dars.gov.et

Sep 20, 2026

Sep 08, 2026

Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge - TipRanks

Sep 08, 2026

Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Sep 08, 2026

Aug 21, 2026

Estrella Immunopharma Receives Nasdaq Minimum Bid Price Notice - TipRanks

Aug 21, 2026

Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 21, 2026

Aug 20, 2026

ARMISTICE CAPITAL, LLC Reduces Stake in Estrella Immunopharma Inc (ESLA) by Nearly Half - GuruFocus

Aug 20, 2026

Aug 16, 2026

Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLong Short Pair - vinanet.vn

Aug 16, 2026

Price to earnings forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Aug 16, 2026

Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLow Risk Entry Stocks - dars.gov.et

Aug 16, 2026

Aug 15, 2026

Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionIchimoku TK Cross - vinanet.vn

Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignInstitutional Buy Signals - vinanet.vn

Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignTriangle Correction - siam.in

Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignScalping Stock Signals - dars.gov.et

Aug 15, 2026

Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionFactor Rotation - dars.gov.et

Aug 15, 2026

Estrella Immunopharma Inc. (NASDAQ: ESLA) Share Price, ESLA Stock News, ESLA Share Price & Updates - kalkine.com.au

Aug 15, 2026

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSystematic Flow - vinanet.vn

Aug 14, 2026

Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake - Stock Titan

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatPost-Earnings Moves - dars.gov.et

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatFibonacci Fan - dars.gov.et

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSingle Stock ETF - dars.gov.et

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatLow Risk Entry Stocks - dars.gov.et

Aug 14, 2026

Aug 13, 2026

Estrella Immunopharma, Inc. 2Q 2026: Net loss $(2.31M), EPS $(0.05) — 10-Q Summary - TradingView

Aug 13, 2026

Tranche Update on Estrella Immunopharma, Inc.'s Equity Buyback Plan announced on January 30, 2024. - marketscreener.com

Aug 13, 2026

Aug 11, 2026

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace

Aug 11, 2026

Estrella adds fourth site to EB103 lymphoma trial - Investing.com

Aug 11, 2026

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance

Aug 11, 2026

Aug 08, 2026